Xalkori

An Update On Pfizer's Recently Approved Drugs

An Update On Pfizer's Recently Approved Drugs

Seeking Alpha

Pfizer May Have To Rethink Xalkori Cost Structure

Pfizer May Have To Rethink Xalkori Cost Structure

Seeking Alpha

Tackling Cancer: Lung Cancer's Biggest Current and Upcoming Players

Tackling Cancer: Lung Cancer's Biggest Current and Upcoming Players

Motley Fool

Is Big Pharma Utilizing Too Many Resources on Potential Blockbusters?

Is Big Pharma Utilizing Too Many Resources on Potential Blockbusters?

Forbes

Pfizer lung cancer drug gets conditional EU approval

Pfizer lung cancer drug gets conditional EU approval

Reuters

Pfizer Lung Cancer Drug Doubles Benefit, Researchers Say

Pfizer Lung Cancer Drug Doubles Benefit, Researchers Say

Bloomberg

Pfizer lung cancer drug achieves Phase 3 endpoint

Pfizer lung cancer drug achieves Phase 3 endpoint

Marketwatch

Pfizer Lung Drug Stops Deadly Child Cancers in Study

Pfizer Lung Drug Stops Deadly Child Cancers in Study

Bloomberg

Pfizer's Xalkori: The Story Can Only Get Better

Pfizer's Xalkori: The Story Can Only Get Better

Seeking Alpha

Summary Box: Pfizer's new lung cancer drug

Summary Box: Pfizer's new lung cancer drug

Yahoo/AP